🔗 Permalink

Inventor profile of:

Thomas E. Jenkins

City:

Half Moon Bay, California

Country:

United States

Published Applications:

Last publication date:

2025-05-22

Top Assignees for applications by Thomas E. Jenkins

The entities that hold a legal rights for patent applications filed by inventor Jenkins Thomas E.:

Signature Therapeutics, Inc. 17 Palo Alto, CA United States
SIGNATURE THERAPEUTICS, INC. 13 San Carlos, CA United States
Elysium Therapeutics, Inc. 4 Danville, CA United States
Elysium Therapeutics, Inc. 3 Akron, OH United States
Singature Therapeutics, Inc. 1 San Carlos, CA United States
Signature Therapeutics, Inc. 1 La Jolla, CA United States
Elysium Therapeutics, Inc. 1 San Ramon, CA United States
Phamacofoce, Inc. 1 San Carrlos, Canada

Recent patent applications by Jenkins Thomas E.

Thomas E. Jenkins from Half Moon Bay, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-22

US20250161468A1

Human necessities

POLYSUBUNIT OPIOID PRODRUGS RESISTANT TO OVERDOSE AND ABUSE

#2 | 2024-11-28

US20240390507A1

Human necessities

POLYSUBUNIT OPIOID PRODRUGS RESISTANT TO OVERDOSE AND ABUSE

#3 | 2024-05-23

US20240165106A1

Human necessities

POLYSUBUNIT OPIOID PRODRUGS RESISTANT TO OVERDOSE AND ABUSE

#4 | 2023-08-03

US20230241054A1

Human necessities

POLYSUBUNIT OPIOID PRODRUGS RESISTANT TO OVERDOSE AND ABUSE

#5 | 2022-06-09

US20220175699A1

Human necessities

COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF

#6 | 2022-02-24

US20220054479A1

Human necessities

OPIOID COMPOSITIONS RESISTANT TO OVERDOSE AND ABUSE

#7 | 2020-08-13

US20200253900A1

Human necessities

Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof

#8 | 2020-04-16

US20200113893A1

Human necessities

Diversion-resistant opioid formulations

#9 | 2020-04-02

US20200101166A1

Human necessities

Polysubunit opioid prodrugs resistant to overdose and abuse

#10 | 2020-03-26

US20200093817A1

Human necessities

Opioid compositions resistant to overdose and abuse

#11 | 2019-06-20

US20190183884A1

Human necessities

Polysubunit opioid prodrugs resistant to overdose and abuse

#12 | 2018-03-29

US20180085366A1

Human necessities

Opioid compositions resistant to overdose and abuse

#13 | 2017-12-28

US20170368058A1

Human necessities

Polysubunit opioid prodrugs resistant to overdose and abuse

#14 | 2017-05-04

US20170119754A1

Human necessities

Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof

#15 | 2017-04-13

US20170100390A1

Human necessities

Polysubunit opioid prodrugs resistant to overdose and abuse

#16 | 2016-08-18

US20160235694A1

Human necessities

Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof

#17 | 2016-05-19

US20160136153A1

Human necessities

Diversion-resistant opioid formulations

#18 | 2016-01-07

US20160002291A1

Chemistry; metallurgy

Active Agent Prodrugs with Heterocyclic Linkers

#19 | 2015-10-22

US20150297736A1

Human necessities

Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof

#20 | 2015-07-16

US20150197544A1

Chemistry; metallurgy

Compositions comprising enzyme-cleavable oxycodone prodrug

#21 | 2015-05-28

US20150148284A1

Human necessities

Controlled Release of Phenolic Opioids

#22 | 2015-01-29

US20150031635A1

Chemistry; metallurgy

Pharmaceutical compositions with attenuated release of phenolic opioids

#23 | 2014-07-24

US20140206773A1

Chemistry; metallurgy

Therapeutic compounds

#24 | 2014-07-24

US20140206597A1

Human necessities

Opioid prodrugs with heterocyclic linkers

#25 | 2014-06-12

US20140162935A1

Human necessities

Compositions comprising enzyme-cleavable oxycodone prodrug

#26 | 2014-05-01

US20140121152A1

Chemistry; metallurgy

Active agent prodrugs with heterocyclic linkers

#27 | 2013-08-22

US20130217783A1

Chemistry; metallurgy

Therapeutic Compounds

#28 | 2013-08-15

US20130210854A1

Human necessities

Compositions Comprising Enzyme-Cleavable Prodrugs of Active Agents and Inhibitors Thereof

#29 | 2013-08-15

US20130210701A1

Human necessities

Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof

#30 | 2013-08-15

US20130210700A1

Human necessities

Compositions Comprising Enzyme-Cleavable Phenol-Modified Opioid Prodrugs and Inhibitors Thereof

#31 | 2013-04-11

US20130090379A1

Human necessities

Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug

#32 | 2013-04-11

US20130089504A1

Human necessities

Compositions Comprising Enzyme-Cleavable Hydromorphone Prodrug

#33 | 2013-03-28

US20130079364A1

Human necessities

Peripheral Opioid Agonists and Peripheral Opioid Antagonists

#34 | 2013-03-07

US20130059919A1

Chemistry; metallurgy

Therapeutic compounds

#35 | 2013-03-07

US20130059914A1

Human necessities

Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof

#36 | 2012-11-22

US20120295834A1

Human necessities

Opioid prodrugs with heterocyclic linkers

#37 | 2012-10-25

US20120270894A1

Human necessities

Controlled release of phenolic opioids

#38 | 2012-09-13

US20120232066A1

Human necessities

COMPOSITIONS FOR REDUCING RISK OF ADVERSE EVENTS CAUSED BY DRUG-DRUG INTERACTIONS

#39 | 2012-09-13

US20120230916A1

Human necessities

Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof

#40 | 2012-08-02

US20120196939A1

Chemistry; metallurgy

Therapeutic compounds

#41 | 2012-07-12

US20120178773A1

Chemistry; metallurgy

Compositions comprising enzyme-cleavable oxycodone prodrug

#42 | 2012-07-12

US20120178772A1

Chemistry; metallurgy

Compositions comprising enzyme-cleavable oxycodone prodrug

#43 | 2012-06-07

US20120142718A1

Chemistry; metallurgy

N-17-Alkylated Prodrugs of Opioids

#44 | 2012-02-09

US20120035271A1

Chemistry; metallurgy

Stereoisomers propofol therapeutic compounds

#45 | 2011-11-17

US20110281886A1

Chemistry; metallurgy

Pharmaceutical compositions with attenuated release of phenolic opioids

#46 | 2010-03-04

US20100056575A1

Chemistry; metallurgy

Anesthetic Compounds

#47 | 2010-02-11

US20100035826A1

Human necessities

Controlled release of phenolic opioids

#48 | 2009-05-28

US20090137618A1

Chemistry; metallurgy

Pro-drugs for controlled release of biologically active compounds

InventorID:

129201 ⎘